Ajanta Pharma Limited — Artemether Exporter Profile
Indian Pharmaceutical Exporter · #7 for Artemether · $15.1M export value · DGFT Verified
Ajanta Pharma Limited is the #7 Indian exporter of Artemether with $15.1M in export value and 391 verified shipments. Ajanta Pharma Limited holds a 1.7% market share in Artemether exports across 27 countries. The company exports 37 pharmaceutical products worth $116.1M across 17 therapeutic categories.
Ajanta Pharma Limited — Artemether Export Profile: Buyers & Destinations
Where Does Ajanta Pharma Limited Export Artemether?
| Country | Value | Shipments | Share |
|---|---|---|---|
| FRANCE | $3.0M | 141 | 45.3% |
| UGANDA | $1.1M | 87 | 16.4% |
| ETHIOPIA | $750.0K | 15 | 11.1% |
| BELGIUM | $343.5K | 18 | 5.1% |
| SUDAN | $286.1K | 6 | 4.3% |
| KENYA | $209.5K | 22 | 3.1% |
| NETHERLANDS | $171.1K | 9 | 2.5% |
| TANZANIA | $156.6K | 13 | 2.3% |
| RWANDA | $113.3K | 25 | 1.7% |
| IVORY COAST | $100.0K | 2 | 1.5% |
Ajanta Pharma Limited exports Artemether to 27 countries. The largest destination is FRANCE accounting for 45.3% of Ajanta Pharma Limited's Artemether shipments, followed by UGANDA (16.4%) and ETHIOPIA (11.1%). These destinations reflect Ajanta Pharma Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Artemether from Ajanta Pharma Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| PLANET PHARMA SA | FRANCE | $2.8M | 135 |
| THE ETHIOPIAN PHARMACEUTICALS | ETHIOPIA | $700.0K | 14 |
| ABACUS PHARMA (A) LTD | UGANDA | $512.2K | 48 |
| FEDERAL MINISTRY OF HEALTH | SUDAN | $250.0K | 5 |
| USAID UGANDA | UGANDA | $200.0K | 4 |
| MSF AZG C O VCK AMSTERDAM | NETHERLANDS | $171.1K | 9 |
| ABACUS PHARMA A LTD | UGANDA | $170.9K | 9 |
| ABACUS PHARMA (A) LIMITED | RWANDA | $169.8K | 37 |
| MSF SUPPLY ASBL CHAUSSEE DE | BELGIUM | $160.5K | 11 |
| MSF SUPPLY ASBL | BELGIUM | $142.2K | 5 |
Ajanta Pharma Limited supplies Artemether to 51 buyers globally. The largest buyer is PLANET PHARMA SA (FRANCE), followed by THE ETHIOPIAN PHARMACEUTICALS (ETHIOPIA) and ABACUS PHARMA (A) LTD (UGANDA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Artemether Export Value and How Much Does Ajanta Pharma Limited Contribute?
India exported $155.1M worth of Artemether through 8,652 shipments from 481 suppliers to 107 countries, serving 1,561 buyers globally. Ajanta Pharma Limited contributes $15.1M to this total, accounting for 1.7% of India's Artemether exports. Ajanta Pharma Limited ships Artemether to 27 countries through 51 buyers.
What Is the Average Shipment Value for Ajanta Pharma Limited's Artemether Exports?
Ajanta Pharma Limited's average Artemether shipment value is $38.7K per consignment, based on 391 shipments totaling $15.1M. The largest destination is FRANCE (45.3% of Ajanta Pharma Limited's Artemether exports).
How Does Ajanta Pharma Limited Compare to Other Indian Artemether Exporters?
Ajanta Pharma Limited ranks #7 among 481 Indian Artemether exporters with a 1.7% market share. The top 3 exporters are IPCA LABORATORIES LIMITED ($30.0M), MACLEODS PHARMACEUTICALS LTD ($25.5M), INNOVA CAPTAB LIMITED ($16.2M). Ajanta Pharma Limited processed 391 shipments to 27 destination countries.
What Artemether Formulations Does Ajanta Pharma Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| ARTEFAN TABLETS 20/120MG[24498PACKX30X24=17638,560 TABS]EACH UNCOATED TABS CONT:ARTEMETHER 20MG AND LUMEFANTRINE 120MG]NOS | $150.0K | 3 |
| ARTEFAN TABLETS 20/120MG[44829PACKX30X24=32276880 TABS]EACH UNCOATED TAB CONT:ARTEMETHER 20MG AND LUMEFANTRINE 120MG]NOS | $150.0K | 3 |
| ARTEFAN TABLETS 20/120 MG [ 15,438 X 30X 24 = 11,115,360 TABLETS] [EACH UNCOATED TABLET CONTAINS : ARTEMETHER 20MG AND | $150.0K | 3 |
| ARTEFAN TABLETS 20/120MG[24060PACKx30x24=17323200 TABS]EACH UNCOATED TAB CONT:ARTEMETHER 20MG AND LUMEFANTRINE 120MG] | $150.0K | 3 |
| ARTEFAN PFOS 40/240 MG ARTEFAN SUSPENSION 40/240 / ARTEMETHER 40MG AND LUMEFANTRINE 240MG PFOS [78540 X 1 = 78540 PACKS]NOS | $112.6K | 3 |
| ARTEFAN TABLETS 20/120MG[240000 X 1 X 24= 5760000 TABLETS][EACH UNCOATED TABLETCONTAINS:ARTEMETHER 20MG AND LUMEFANTRI | $109.9K | 3 |
| ARTEFAN TABLETS 20 120MG 90000PAC X 1 X24 2160000 TABLETS ARTEMETHER AND LUMEFANTRINE TABLETS 20 120MG | $100.0K | 2 |
| ARTEFAN SUSP 180/1080MG[45090X1=45090 BOTTLES](EACH UNCOATED POWDER CONTAINS : ARTEMETHER 180MG AND LUMEFANTRINE 1080MG)NOS | $98.2K | 3 |
| ARTEFAN TABLETS 20 120MG 75 000 X 1 X 24 1 800 000 TABLETS ARTEMETHER AND LUMEFANTRINE TABLETS 20 120MG CONT AS PER I | $87.0K | 2 |
| ARTEFAN TABLETS 20 120MG 75000PAC X 1 X24 1800000 TABLETS ARTEMETHER AND LUMEFANTRINE TABLETS 20 120MG | $87.0K | 2 |
Ajanta Pharma Limited exports 313 distinct Artemether formulations including tablets, capsules, syrups, and combination drugs. The top formulation is ARTEFAN TABLETS 20/120MG[24498PACKX30X24=17638,560 TABS]EACH with 3 shipments worth $150.0K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.
How Does Ajanta Pharma Limited Compare to Nearest Artemether Exporters?
Exporters ranked immediately above and below #7 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 2 | MACLEODS PHARMACEUTICALS LTD | $25.5M | 510 | 53 | $50.0K |
| 3 | INNOVA CAPTAB LIMITED | $16.2M | 324 | 5 | $50.0K |
| 7 | AJANTA PHARMA LIMITED ★ | $15.1M | 391 | 27 | $38.7K |
| 8 | S K AGE EXPORTS | $9.1M | 237 | 16 | $38.2K |
| 6 | AFROWAY PHARMA | $8.6M | 171 | 3 | $50.0K |
Ajanta Pharma Limited ranks #7 among 481 Indian Artemether exporters. Average shipment value of $38.7K compared to the market average of $322.4K. The closest competitors by value are MACLEODS PHARMACEUTICALS LTD and INNOVA CAPTAB LIMITED.
Which Indian Ports Ship Artemether Exports?
| Port | Shipments | % Share |
|---|---|---|
| NHAVA SHEVA SEA (INNSA1) | 1,326 | 15.3% |
| JNPT/ NHAVA SHEVA SEA | 817 | 9.4% |
| JNPT | 788 | 9.1% |
| SAHAR AIR | 757 | 8.7% |
| SAHAR AIR CARGO ACC (INBOM4) | 622 | 7.2% |
| AHEMDABAD ICD | 420 | 4.9% |
| NHAVA SHEVA SEA | 272 | 3.1% |
| MUNDRA SEA | 269 | 3.1% |
Geopolitical & Trade Policy Impact on Ajanta Pharma Limited's Artemether Exports
Ajanta Pharma's export operations are intricately linked to global trade routes, making them susceptible to geopolitical tensions. The ongoing Israel-Iran conflict has disrupted shipping lanes in the Red Sea, leading to increased freight costs and extended delivery timelines. Such disruptions pose challenges for Indian pharmaceutical exporters like Ajanta, necessitating adaptive logistics strategies to maintain supply chain integrity. (pharmaceuticalcommerce.com)
Conversely, the US-China trade tensions have opened avenues for Indian pharmaceutical companies to strengthen their foothold in the American market. India's pharmaceutical exports to the US surged by 74% in March 2025, indicating a shift in sourcing preferences. Ajanta Pharma can leverage this trend by emphasizing its compliance with stringent US regulatory standards and offering competitive pricing. (business-standard.com)
In the European Union, adherence to the Falsified Medicines Directive (FMD) is paramount. Indian exporters, including Ajanta, must ensure robust serialization and traceability measures to comply with these regulations. Non-compliance could result in restricted market access, underscoring the importance of investing in advanced tracking systems and quality assurance protocols.
Ajanta Pharma Limited — Regulatory Compliance & Quality Standards
The global pharmaceutical industry is witnessing heightened regulatory scrutiny, with agencies like the US FDA, WHO, and EU GMP setting stringent compliance benchmarks. India has made significant strides in this arena, surpassing the US in the number of FDA-registered generic manufacturing sites, boasting 752 FDA-approved facilities as of 2024. (business-standard.com) Ajanta Pharma's commitment to quality is evident in its adherence to these international standards, facilitating smoother market entry and bolstering its reputation among global stakeholders.
About Ajanta Pharma Limited
Ajanta Pharma Limited exports 37 products worth $116.1M. Beyond Artemether, top products include Amlodipine, Clopidogrel, Rosuvastatin, Montelukast, Valsartan. View the complete Ajanta Pharma Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Artemether — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Artemether shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Ajanta Pharma Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 391 individual customs records matching Ajanta Pharma Limited exporting Artemether, covering 313 formulations to 27 countries via 51 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 107+ countries, 1,561+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Artemether Export Data from Ajanta Pharma Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Ajanta Pharma Limited's Artemether exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Ajanta Pharma Limited
Full Company Profile →
37 products · $116.1M total trade · 17 categories
Artemether Stats
Company Overview
Top Products by Ajanta Pharma Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Ajanta Pharma Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Artemether. For current shipment-level data, contact TransData Nexus.